Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Fresh Tracks Therapeutics Inc FRTX

Healthcare Biotechnology
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.

Recent & Breaking News (GREY:FRTX)

Vical to Present at JMP Securities Healthcare Conference

Globe Newswire July 3, 2013

Vical and Astellas Announce Initiation of Phase 3 Trial of ASP0113 Cytomegalovirus Vaccine

Globe Newswire June 25, 2013

Vical to Present at Wells Fargo Securities Healthcare Conference

Globe Newswire June 12, 2013

Vical Appoints Richard M. Beleson and Stephen A. Sherwin, M.D., to Board of Directors

Globe Newswire May 23, 2013

Vical Reports First Quarter 2013 Financial Results and Progress in Key Development Programs

Globe Newswire May 9, 2013

Vical to Present at May Investor Conferences

Globe Newswire May 7, 2013

Vaxfectin(R) Enhances Preclinical Immune Responses to Baxter's Cell Culture-Derived Influenza Vaccines

Globe Newswire May 6, 2013

Vical Announces News Release and Conference Call Schedule for First Quarter 2013 Financial Results

Globe Newswire May 2, 2013

Vical CEO to Participate in Cancer Immunotherapy Panel at BIO International Convention

Globe Newswire April 22, 2013

Free Research Reports on ASTX, MELA, REE and VICL Issued by the Bedford Report

Marketwired March 7, 2013

U.S. Food and Drug Administration Approved 30% More Drugs in 2012 than the Year Previous

Marketwired February 27, 2013

Vical to Present at March Investor Conferences

Troy Schwensen February 27, 2013

Vical Reports 2012 Financial Results and Progress in Key Development Programs

Troy Schwensen February 6, 2013

Vical to Present at February Investor Conferences

Troy Schwensen February 5, 2013

Vical Announces Publication of Herpes Simplex Vaccine Guinea Pig Study Data

Troy Schwensen February 4, 2013

Biotech Industry Expected to Experience More Merger & Acquisition Activity in 2013

Marketwired January 30, 2013

Vical Announces News Release and Conference Call Schedule for 2012 Financial Results

Troy Schwensen January 30, 2013

Vical to Present at 31st Annual J.P. Morgan Healthcare Conference

Troy Schwensen January 3, 2013

Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry's Success in 2012

Marketwired January 2, 2013

Vical Named to NASDAQ Global Select Market

Troy Schwensen January 2, 2013